Article
Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: reappraisal of interindividual variability factors.
Therapeutic drug monitoring - 1 Feb 1999
Balant-Gorgia A E, Gex-Fabry M, Genet C, Balant L P
Abstract excerpt
Because of the enormous gap between premarketing studies in physically healthy subjects and clinical practice in patients, the present study reconsidered interindividual variability factors affecting risperidone concentrations under routine therapeutic drug monitoring conditions. The study included 92 patients, 27% of whom were 70 years or older. The patients received risperidone orally (dose range, 0.5-11 mg per...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.